Uji klinis HIV di Texas
23 studi untuk HIV mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Abounding Prosperity Inc., Dallas
- Prism Health, Dallas
- UT Health, Houston
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, Dallas
- dan 2 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07650916ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
- Baylor College of Medicine, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06274632A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire
- Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas
- Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth
- dan 1 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07266831Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Menerima pesertaFase 1/2
48 Hours · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT02140255Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
- M D Anderson Cancer Center, Houston
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02479698A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
- The Crofoot Research Center, Houston
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07698600Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- University of Texas M.D. Anderson Cancer Center, Houston
Menerima peserta
Usia 45 hingga 80 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04949464Positive Peers Intervention Clinical Trial
- Thomas Street Clinic, Houston
Menerima peserta
Usia 13 hingga 34 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06388109Screen2Prevent (S2P)
- Baylor College of Medicine, Houston
Menerima pesertaSukarelawan sehat diterima
Usia 14 hingga 24 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- North Texas Infectious Diseases Consultants, P.A., Dallas
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07682961First Time in Human Study of Long Acting VH4524184 Formulations
- GSK Investigational Site, San Antonio
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06310551A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- UT Health Houston, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07143968A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Bellaire
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07202546Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
- Houston Methodist Research Institute, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06263426Menopausal HT for Women Living With HIV (HoT)
- Houston AIDS Research Team CRS (31473), Houston
Menerima pesertaFase 4
Usia 40 hingga 60 · Wanita · Diperbarui 22 Mei 2026 · NCT06856174Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
- The University of Texas Health Science Center at Houston, Houston
Menerima peserta
Usia 18 hingga 25 · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06074354HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- UT Southwestern Medical Center, Dallas
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT06659952The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
- UT Southwestern Medical Center, Dallas
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 15 Jan 2026 · NCT07292792A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- GSK Investigational Site, Austin
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 18 Des 2025 · NCT05418868Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- UT Health Houston, Houston
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 17 Des 2025 · NCT05488431A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- GSK Investigational Site, Austin
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06724640Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Menerima pesertaFase 1/2
Usia 6 hingga 12 · Semua jenis kelamin · Diperbarui 19 Sep 2024 · NCT05674656Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.